Detection of disseminated tumor cells in peripheral blood
- PMID: 15941083
- DOI: 10.1080/10408360590913696
Detection of disseminated tumor cells in peripheral blood
Abstract
Metastases are the major cause of cancer-related deaths in patients with solid epithelial malignancies, such as breast, colorectal and prostate carcinomas. Hematogenous spreading of tumor cells from a primary tumor can be considered as a crucial step in the metastasis cascade leading eventually to the formation of clinically manifest metastases. Consequently, as shown in recent studies, the detection of disseminated tumor cells in peripheral blood might be of clinical relevance with respect to individual patient prognosis and staging or monitoring of therapy. However, the rarity of disseminated tumor cells in peripheral blood renders the application of sensitive techniques mandatory for their detection. The emergence of highly sophisticated reverse transciptase-polymerase chain reaction (RT-PCR) assays, combining a preanalytical enrichment step with the assessment of multiple molecular tumor markers expressed in disseminated tumor cells, provides a powerful tool in detecting disseminated tumor cells with high sensitivity and specificity. This review will discuss currently used tumor markers as well as experimental means to enhance the sensitivity and specificity of RT-PCR assays to detect disseminated tumor cells in the peripheral blood of patients with breast, colorectal, and prostate cancers, and their clinical relevance assessed in recent studies.
Similar articles
-
Real-time RT-PCR systems for CTC detection from blood samples of breast cancer and gynaecological tumour patients (Review).Oncol Rep. 2016 Apr;35(4):1905-15. doi: 10.3892/or.2016.4608. Epub 2016 Feb 2. Oncol Rep. 2016. PMID: 26848098 Review.
-
Optimal markers for real-time quantitative reverse transcription PCR detection of circulating tumor cells from melanoma, breast, colon, esophageal, head and neck, and lung cancers.Clin Chem. 2007 Jul;53(7):1206-15. doi: 10.1373/clinchem.2006.081828. Epub 2007 May 24. Clin Chem. 2007. PMID: 17525108
-
Detection of Survivin-expressing circulating cancer cells in the peripheral blood of breast cancer patients by a RT-PCR ELISA.Clin Exp Metastasis. 2006;23(5-6):279-89. doi: 10.1007/s10585-006-9037-7. Epub 2006 Nov 3. Clin Exp Metastasis. 2006. PMID: 17086357 Clinical Trial.
-
Detection of circulating breast cancer cells in peripheral blood by a two-marker reverse transcriptase-polymerase chain reaction assay.Acta Biochim Pol. 2004;51(3):747-55. Acta Biochim Pol. 2004. PMID: 15448736
-
Molecular detection of micrometastases and circulating tumor cells in melanoma prostatic and breast carcinomas.In Vivo. 2000 Jan-Feb;14(1):237-50. In Vivo. 2000. PMID: 10757082 Review.
Cited by
-
Untethered Micro/Nanorobots for Remote Sensing: Toward Intelligent Platform.Nanomicro Lett. 2023 Nov 30;16(1):40. doi: 10.1007/s40820-023-01261-9. Nanomicro Lett. 2023. PMID: 38032461 Free PMC article. Review.
-
Circulating Tumor Cells are an Independent Risk Factor for Poor Prognosis in Patients with Gallbladder Adenocarcinoma.Ann Surg Oncol. 2023 Dec;30(13):7966-7975. doi: 10.1245/s10434-023-14231-7. Epub 2023 Aug 27. Ann Surg Oncol. 2023. PMID: 37635189
-
Comparison of sample preparation methods for rare cell isolation in microfluidic devices.Can J Chem. 2022 Jul;100(7):512-519. doi: 10.1139/cjc-2021-0229. Epub 2022 Jan 19. Can J Chem. 2022. PMID: 36338875 Free PMC article.
-
Hydrodynamic Cavitation on a Chip: A Tool to Detect Circulating Tumor Cells.ACS Appl Mater Interfaces. 2022 Sep 14;14(36):40688-40697. doi: 10.1021/acsami.2c12356. Epub 2022 Sep 1. ACS Appl Mater Interfaces. 2022. PMID: 36048001 Free PMC article.
-
Unraveling Cancer Metastatic Cascade Using Microfluidics-based Technologies.Biophys Rev. 2022 Apr 14;14(2):517-543. doi: 10.1007/s12551-022-00944-8. eCollection 2022 Apr. Biophys Rev. 2022. PMID: 35528034 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical